Mariner
VIR icon

Mariner’s Vir Biotechnology VIR Stock Holding History

Mariner’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$323K Buy
+36,037
New +$287K ﹤0.01% 2801
2024
Q2 		– Sell
-10,971
Closed -$111K – 3294
2024
Q1 		$111K Sell
10,971
-7
-0.1% -$71 ﹤0.01% 2911
2023
Q4 		$110K Buy
+10,978
New +$100K ﹤0.01% 2840

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Mariner's VIR Position: Q1 2026 in Review

Mariner opened a new position in Vir Biotechnology (VIR) in Q1 2026: 36,037 shares worth $323K. The stake represents ﹤0.01% of the portfolio and ranks #2801 among its holdings. This is a return to the name: Mariner previously reported a position in VIR as recently as Q1 2024.

Mariner first reported a position in VIR in Q4 2023 and has held it in 3 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Mariner held 36,037 shares of Vir Biotechnology worth $323K as of Q1 2026.
  • Vir Biotechnology was a new Mariner position in Q1 2026.
  • Vir Biotechnology made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2801 holding.
  • Mariner first reported a position in Vir Biotechnology in Q4 2023 and has held it in 3 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.